Fractional Go-to-Market Strategist (Scientific AI Platform | B2B SaaS | Life Sciences)

ScitoVation is building a new generation of software for computational toxicology and regulatory science. Our platform ScitoSim® helps scientists, product stewardship teams, and regulatory organizations answer complex safety questions by combining structured evidence synthesis, transcriptomics, physiologically based pharmacokinetic (PBPK) modeling, and AI-assisted scientific workflows. Unlike many AI companies, our goal isn't to replace scientific expertise. It's to make expert science faster, more transparent, reproducible, and accessible. The platform is built on nearly a decade of validated scientific work performed by ScitoVation, a recognized leader in computational toxicology and New Approach Methodologies (NAMs). Our team has contributed to more than 100 peer-reviewed publications and supported major industry associations, global manufacturers, and regulatory-facing projects. We're now looking for an experienced commercialization partner to help us define and execute the next stage of our go-to-market strategy. See attached document for more details on what we're looking for.